Worldwide Huntington's Disease Industry to 2029 - A Robust Product Pipeline of Disease-Modifying Treatments is Expected to Drive the Market - ResearchAndMarkets.com

×

Error message

  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ds_changed in eval() (line 16 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$ss_search_api_url in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).
  • Notice: Undefined property: stdClass::$tm_title in eval() (line 20 of /var/www/7/modules/php/php.module(80) : eval()'d code).

The "Huntington's Disease Market Analysis by Treatment (Disease-modifying Therapies, Symptomatic Treatment) and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Tuesday, November 15, 2022
Information
Tags: 
Health, Pharmaceutical, Chorea, Huntington's disease, Prevalence, Region, Disease, USD, Valbenazine, HD, Treatment, Pharmaceutical industry
Organisation: 
RESEARCH AND MARKETS
Summary
Key Points: 
  • The "Huntington's Disease Market Analysis by Treatment (Disease-modifying Therapies, Symptomatic Treatment) and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.
  • The Hutington's Disease market size is estimated to be USD 475.3 million in 2021 and is expected to witness a CAGR of 21.61% during the forecast period 2022-2029.
  • Ingrezza's expected label expansion for treating chorea associated with Huntington's disease, the high prevalence of HD in Western countries, and a robust product pipeline of disease-modifying treatments is expected to drive the market.
  • However, low success rate in clinical trials is expected to restrain the market growth.


The "Huntington's Disease Market Analysis by Treatment (Disease-modifying Therapies, Symptomatic Treatment) and by Region - Global Forecast to 2029" report has been added to ResearchAndMarkets.com's offering.

The Hutington's Disease market size is estimated to be USD 475.3 million in 2021 and is expected to witness a CAGR of 21.61% during the forecast period 2022-2029.

Ingrezza's expected label expansion for treating chorea associated with Huntington's disease, the high prevalence of HD in Western countries, and a robust product pipeline of disease-modifying treatments is expected to drive the market. However, low success rate in clinical trials is expected to restrain the market growth.

Segmentation: Hutington's Disease Market Report 2021-2029

By Treatment (Revenue, USD Million)

  • Disease-modifying Therapies
  • Symptomatic Treatment

By Region (Revenue, USD Million)

North America

  • U.S
  • Canada

Europe

  • Germany
  • France
  • UK
  • Spain
  • Italy
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of APAC

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Rest of LATAM

Middle East & Africa

  • South Africa
  • GCC
  • Rest of MEA

Companies Mentioned

  • Teva (Israel)
  • Novartis AG (Switzerland)
  • GSK (UK)
  • AbbVie (US)
  • Merck (US)
  • Boehringer Ingelheim (Germany)
  • Impax Laboratories (US)
  • Lundbeck (Denmark)
  • UCB (Belgium)
  • Valeant Pharmaceuticals (Canada)
  • Acadia (US)
  • Sun Pharma (India)
  • Wockhardt (India)
  • Dr. Reddy's (India)
  • Intas (India)
  • US WorldMeds (US)
  • Zydus Cadila (India)
  • Cipla (India)
  • Strides (India)
  • 1 A Pharma (India)
  • Upsher-Smith (US)

For more information about this report visit https://www.researchandmarkets.com/r/aboj38

Copyright: 
Copyright Business Wire 2022